The Evolving Strategies in HIV Management and Clinical Updates on Injectable and Implantable Therapies

The Evolving Strategies in HIV Management and Clinical Updates on Injectable and Implantable Therapies

Faculty Presenters

Babafemi O. Taiwo, MD, MBBS
Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University
Chicago, Illinois

Matthew Nguyen, PharmD
Associate Director, Clinical Services
MC-RX
Atlanta, Georgia

Milena Murray, PharmD, MSc, BCIDP, AAHIVP
Associate Professor
Midwestern University
HIV/ID Clinical Pharmacist
Northwestern Memorial Hospital
Downers Grove, Illinois
 

---

Program Description
Once a fatal condition, HIV is now considered a manageable and preventable chronic illness, though it requires a lifetime of medical care. Over time, the economic burden of HIV has shifted from direct costs of hospitalizations associated with advanced disease to costs associated with outpatient visits, lab tests, and antiretroviral therapy (ART). ART is the cornerstone of therapy for active, chronic HIV infection, and treatment with these agents targets to decrease HIV RNA viral load to levels that are undetectable; however, choice of antiviral is complicated by pill burden and may further vary based on patient-specific factors and comorbidities. Managed care professionals have an important role in collaborating with clinicians to help people living with HIV remain adherent to their prescribed ART regimen and be engaged in their medical care. Pharmacists must recognize the potential advantages and emerging data for novel long-acting injectable and implantable ART formulations that may prevent treatment failure, improve adherence, and, ultimately, improve quality of life for people living with HIV.

Target Audience: Managed care payers, pharmacy directors, pharmacy benefit managers, specialty pharmacy directors, and any other pharmacist and/or healthcare professional interested in therapies for HIV treatment and prevention.
Type of Activity: Application
Fee: Free

Educational Objectives
At the completion of this activity, participants will be able to:

• Examine the clinical implications and value of adherence to antiretroviral therapy (ART) and preexposure prophylaxis (PReP) therapy
• Analyze the mechanism of action, administration, and efficacy and safety data of emerging treatment strategies aimed at improving adherence
• Articulate the economic and health-related value of preventing infection and maintaining HIV viral load suppression

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-20-327-H01-P. The activity is available for CE credit through October 30, 2021.


Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the webcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

---

Disclosures

Faculty
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, has the following relevant financial relationship with a commercial interest to disclose:

• Speakers Bureau: Merck Sharp & Dohme Corp.

Babafemi O. Taiwo, MD, MBBS, has the following relevant financial relationships with commercial interests to disclose:

• Consultant: Gilead, GlaxoSmithKline, Merck Sharp & Dohme Corp., ViiV Healthcare

Matthew Nguyen, PharmD, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Rose Namissa, PharmD, BCPS; Crissy Wilson; Susan Pordon; and Brianna Winters have no relevant financial relationships with commercial interests to disclose.

Anonymous peer reviewers are used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this live CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms